Dr. Hilda Capo, MD

Dr. Capo practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Capo's NPI, 1972546653, was assigned on June 13, 2006. Dr. Capo graduated from University of Puerto Rico, Medical Sciences Campus in 1982. Dr. Capo holds Florida license ME55918.

Dr. Capo's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Capo's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Capo to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Capo practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Capo's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Capo is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Capo is licensed in Florida.

Dmand AI lists eye infection or inflammation and vision problems among the conditions Dr. Capo treats.

CMS data shows 233 Medicare services from Dr. Capo across 6 procedure codes in 2024, for 114 Medicare patients. Medicare paid $23,471 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Capo in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high cholesterol, and 59% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Capo's median patient age at 59, with 55% women.

In 2024, Dr. Capo wrote 86 Medicare Part D claims for 56 patients. 85% of them were for generic drugs. CMS names the drug for 56 of them, across 1 drug with 11 or more claims each, at $659 in total drug cost. In 2023, CMS named 45 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Capo for performance year 2024, reported as part of a group. Dr. Capo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 33 papers to Dr. Capo, published from 2003 to 2024. 2017 was the busiest year, with 6. The most frequent topics are Oculomotor Muscles, Strabismus and Eye Movements. Dr. Capo has published most often in J AAPOS. Dr. Capo's most frequent co-authors are Kara Marie Cavuoto, MD, Sara Fransen Grace, MD and Craig A. McKeown, MD.

CMS Open Payments shows 13 general payments to Dr. Capo from 9 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $200.

Dmand AI lists 6 awards for Dr. Capo, most recently America's Top Doctors in 2014.

Dr. Capo graduated from University of Puerto Rico, Medical Sciences Campus in 1982. Dr. Capo is a member of AAO.

Dr. Capo is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.